We attempted to send a notification to your email address but we were unable to verify that you provided a valid email address.
Please visit my profile to update your email address if you wish to receive notifications.
Otherwise, disable notifications and hide this message.
Your session was unable to be renewed and will be expiring in 0 seconds.
Click here to attempt to renew your session.
Kaigene Enters into Exclusive Licensing Agreement with Celltrion for Novel Antibody Therapeutics in Autoimmune Diseases
![[Loading...]](https://media-sixrivers.mynews360.com/images/loading.gif "Loading...")
